RNA induction of an epigenetic hereditary pathology

A new study shows that microinjection of RNA molecules into mouse embryos induces a hereditary form of cardiac hypertrophy that is similar to human hypertrophic cardiomyopathy (HCM). The research, published by Cell Press in the June issue of the journal Developmental Cell, may provide a paradigm for clinical cases of familial diseases not readily explained by DNA mutations.

Dr. Minoo Rassoulzadegan from the University of Nice and her colleagues had previously shown that RNA, a molecule that is similar to DNA and important for the process of protein synthesis, can play an unexpected role in passing characteristics on to future generations, even in the absence of DNA mutations affecting those characteristics. This phenomenon is known as hereditary epigenetic determination, or paramutation.

The researchers sought to expand on this earlier work by examining the relevance of paramutation to pathophysiology and disease. They focused on HCM, an important often hereditary heart disease characterized by enlargement of cardiac muscle cells. "There is no clear molecular link between mutations associated with hereditary cardiomyopathies, inheritance of the disease and the abnormal growth of cardiac muscle cells, leading to the suspicion that other, still unknown factors are involved," offers Dr. Rassoulzadegan.

Dr. Rassoulzadegan's group used their method to show that injecting microRNA-1, a known regulator of cardiac development, into one-cell mouse embryos resulted in mice with substantially enlarged hearts similar to HCM. The injected RNA initiated epigenetic changes in targets such as Cdk9, a gene that regulates cardiac growth. Remarkably, these changes were then inherited both paternally and maternally for three generations. The authors attribute this phenomenon to the transmission of the excess microRNA via sperm.

The authors conclude that hereditary human cardiac problems that do not seem linked to DNA mutations may be caused instead by aberrant RNAs. "These results highlight the diversity of RNA-mediated epigenetic effects. They extend the concept of a mode of variation and heredity, distinct from and complementary to principles of Mendelian genetics, an observation that is potentially significant for both fundamental biology and pathology," says Dr. Rassoulzadegan.

Source: Cell Press

Related stories:

Angina drug potentially useful against heart rhythm disorders
A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for sudden cardiac death, according to research presented to today at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.
Life-threatening gene defect located by UT-Houston researchers
A research team led by scientists at The University of Texas Medical School at Houston has identified a defective gene that affects vascular smooth-muscle cells in people who suffer from hereditary thoracic aortic disease, which can kill victims with little warning in the prime of their lives.
Researchers discover inherited mutation for leukemia
Researchers have discovered the first inherited gene mutation that increases a person's risk for chronic lymphocytic leukemia (CLL), one of the most common forms of the disease.
Tiny Clue Reveals New Path Toward Heart Disease
Geneticists have discovered a new gene that may put individuals at higher risk of developing cardiovascular disease.
Ghost Protein Leaves Fresh Tracks in the Cell
Spectrin and ankyrin are two essential proteins acting like bricks and mortar to shape and fortify cell membranes. But distinguishing which protein is the brick and which is the mortar has turned out to be difficult. New evidence suggests that spectrin can do both jobs at once.
FDA approves first drug for Huntington's disease
The U.S. Food and Drug Administration today approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease.
Genes may make some people more prone to anxiety
Inborn differences may help explain why trauma gives some people bad memories and others the nightmare of post-traumatic stress. Scientists in Germany and the United States have reported evidence linking genes to anxious behavior. The findings appear in the August issue of Behavioral Neuroscience, published by the American Psychological Association.
Key site in iron metabolism aids in diagnosing anemia of chronic disease
University of Utah School of Medicine researchers have developed a new tool that facilitates diagnosis of anemia related to chronic illness, as well as diseases of iron overload. The results of a study detailing the new tool are published in the August 2008 issue of the journal Cell Metabolism, a publication of Cell Press.

News discussion:

General Science news